- Home
- PHH vs SIGA Comparison
PHH vs SIGA Comparison
Compare PHH & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHH
- SIGA
- Stock Information
- Founded
- PHH 2016
- SIGA 1995
- Country
- PHH China
- SIGA United States
- Employees
- PHH N/A
- SIGA N/A
- Industry
- PHH Package Goods/Cosmetics
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- PHH Consumer Discretionary
- SIGA Health Care
- Exchange
- PHH Nasdaq
- SIGA Nasdaq
- Market Cap
- PHH 363.4M
- SIGA 422.9M
- IPO Year
- PHH 2024
- SIGA 1997
- Fundamental
- Price
- PHH $14.42
- SIGA $6.08
- Analyst Decision
- PHH
- SIGA
- Analyst Count
- PHH 0
- SIGA 0
- Target Price
- PHH N/A
- SIGA N/A
- AVG Volume (30 Days)
- PHH 330.8K
- SIGA 439.9K
- Earning Date
- PHH 01-01-0001
- SIGA 05-08-2025
- Dividend Yield
- PHH N/A
- SIGA 9.82%
- EPS Growth
- PHH N/A
- SIGA N/A
- EPS
- PHH 0.02
- SIGA 0.67
- Revenue
- PHH $2,381,851.00
- SIGA $120,330,310.00
- Revenue This Year
- PHH N/A
- SIGA N/A
- Revenue Next Year
- PHH N/A
- SIGA $95.31
- P/E Ratio
- PHH $785.34
- SIGA $8.91
- Revenue Growth
- PHH N/A
- SIGA N/A
- 52 Week Low
- PHH $3.70
- SIGA $4.95
- 52 Week High
- PHH $16.56
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- PHH N/A
- SIGA 54.60
- Support Level
- PHH N/A
- SIGA $5.71
- Resistance Level
- PHH N/A
- SIGA $6.23
- Average True Range (ATR)
- PHH 0.00
- SIGA 0.21
- MACD
- PHH 0.00
- SIGA 0.02
- Stochastic Oscillator
- PHH 0.00
- SIGA 71.15
About PHH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.